Abstract
The heat-stable and soluble glycoprotein gp200 (molecular weight 200 kDa) is part of the cell wall of S. cerevisiae. Recently, an association was shown between IgA and IgG against gp200 and inflammation in Crohn's disease. Gp200 is able to induce a proliferation of human lymphocytes in vitro, together with a natural killer cell associated cytotoxicity. Specific IgE against Saccharomyces cerevisiae (baker's or brewer's yeast) may be detected in approximately 73 %, against Candida albicans in 68% of those patients suffering from severe atopic dermatitis. The aim of this study was to elucidate the possible role of an anti-gp200 immune response for the pathogenesis of atopic dermatitis by immunoblot analysis.
Anti-gp200 IgE was found in 55% of healthy individuals, in 67% of individuals with atopic predisposition without eczema, in 63% of the patients with mild atopic dermatitis, and in 86% of patients with severe atopic dermatitis, respectively. On the contrary, anti-gp200 IgG could be shown in 55% of healthy individuals, in 89% of individuals with atopic predisposition but without eczema, in 100% of patients with mild atopic dermatitis, and in 79% with severe atopic dermatitis, respectively. No immunoreactivity was found when an extract of Arxula adeninivorans was used as antigen. These results underline the specificity of the immunoblot results with gp200 from Saccharomyces cerevisiae. It can be concluded that occurrence of specific IgE against Saccharomyces cerevisiae cannot be explained by a cross reactivity, e.g., against Candida albicansallergens. Further investigations with the recombinant gp200 will give information on the role of this glycoprotein both in atopic dermatitis and Morbus Crohn.
Similar content being viewed by others
References
Ballou CE. Structure and biosynthesis of the mannan component of the yeast cell envelope. Adv Microbiol Physiol 1976; 14: 97–109.
Barnes RMR, Allan S, Taylor-Robinson CH, Finn R, Johnson PM. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol 1990; 92: 9–15.
Bröker M, Harthus H-P, Barnes RMR. A murine monoclonal antibody directed against a yeast cell wall glycoprotein antigen of the yeast genus Saccharomyces. FEMS Microbiol Lett 1994; 118: 297–304.
Darroch CJ, Christmas SE, Barnes RMR. In vitro human lymphocyte proliferative responses to a glycoprotein of the yeast Saccharomyces cerevisiae. Immunology 1994; 81: 247–252.
Diepgen TL, Fartasch M, Hornstein OP. Kriterien zur Beurteilung der atopischen Hautdiathese. Dermatosen 1991; 39: 79–83.
Doekes G, Kaal MJH, Van Ieperen-Van Dijk AG. Allergens of Pityrosporum ovale and Candida albicans. Physiochemical characterization. Allergy 1993; 48: 401–408.
European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European ask force on atopic dermatits. Dermatology 1993; 186: 23–31.
Gatti E, Popolo L, Vai M, Rota N, Alberghina I. O-linked oligosaccharides in yeast glycosyl phosphatidylinositolanchlored protein gp115 are clustered in a serine rich region not essential for its function. J Biol Chem 1994; 269: 19695–19700.
Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992; 33: 1071–1075.
Hanifin JM, Rajka G. Diagnostic features of atopic dermatits. Acta Derm Venerol (Stockh) 1980; 92: 44–47.
Heelan BT, Allan S, Barnes RMR. Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae. Immunol Lett 1991; 28: 181–186.
Huang X, Johansson SGO, Zagari A, Nordvall S L. Allergen cross-reactivity between Pityrosporum orbiculare and Candida albicans. Allergy 1995; 50: 648–656.
Kortekangas-Savolainen O, Kalimo K, Lammintausta K, Savolainen J. IgE binding component of bakers yeast (Saccaromyces cerevisiae) recognized by immunoblotting analysis. Simultaneous IgE binding to mannan and 46 and 48 kDa allergens of Saccharomyces cerevisiae and Candida albicans. Clin Exp Allergy 1993; 23: 179–184.
Kunze G, Kunze I. Arxula adeninivorans. In: Wolf K, ed. Nonconventional yeasts in biotechnology. Berlin: Springer 1996: 389–409.
Kurup VP, Banerjee B (2000) Fungal allergens and peptide epitopes. Peptides 21, 589–599.
Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.
Lintu P, Savolainen J, Kalimo K, Kortekangas-Savolainen O, Nermes M, Terho EO. Cross-reacting IgE and IgG antibodies to Pityrosporum ovale mannan and other yeasts in atopic dermatitis. Allergy 1999; 54: 1067–1073.
McKenzie H, Main J, Pennington CR, Parrat D. Antibody to selected strains of Saccharomyces cerevisiae (baker's and 21 brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990; 31: 536–538.
Menzel I. Zur Provokation der Dermatitis atopica durch intestinale Candidamykose. Z Hautkr 1984; 59: 1463–1468.
Sander U, Kunze I, Bröker M, Kunze G. Humoral immune response to a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae is common in man. Immunol Lett 1998; 61: 113–117.
Savolainen J, Kosonen J, Lintu P Vianders M, P?ne J, Kalimo K, Terho EO, Bousquet J. Candida albicans mannanand protein-induced humoral, cellular and cytokine responses in atopic dermatitis patients. Clin Exp Allergy 1999; 29: 824–831.
Savolainen J, Broberg A. Cross-reacting IgE antibodies to Pityrosporum ovale and Candida albicans in atopic children. Clin Exp Allergy 1992; 22: 469–474.
Savolainen J, Kortekangas-Savolainen O, Nermes M, Viander M, Koivikko A, Kalimo K, Terho EO. IgE, IgA, and IgG responses to common yeasts in atopic patients. Allergy 1998; 53: 506–512.
Shen H-D, Choo K-B, Lee H-H, Hsieh J-C, Lin W-L, Lee WR, Han S-H. The 40 kilodalton allergen of Candida albicans is an alcohol dehydrogenase: molecular cloning and immunological analysis using monoclonal antibodies. Clin Exp Allergy 1991; 21: 675–681.
Tanaka M et al. Reduced proliferation responses of peripheral blood mononuclear cells specifically to Candida albicans antigen in patients with atopic dermatitis-comparison with their normal reactivity to bacterial superantigens. Arch Dermatol Res 1996; 288: 495–499.
Tengvall Lindner M, Johansson C, Zagari A. Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles. Clin Exp Allergy 1996; 26: 1286–1297.
Towbin HT, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1977; 76: 4350–4354.
Waersted A, Hjorth N. Pityrosporum orbiculare. A pathogenic factor for atopic dermatitis of the face, scalp, and neck? Acta Derm Venereol 1985; 114: 146–148.
Young M, Haavik S, Paulsen BS, Bröker M, Barnes RMR: Further characterization of a high molecular weight glycoprotein antigen from the yeast Saccharomyces cerevisiae. Carbohydrate Polymers 1996; 30: 243–252.
Zschiesche A, Nenoff P, Bauroth U, Stangl A, Haustein UF. Untersuchung zur Häufigkeit positiver spezifischer IgE-Tests auf Hefe-und Schimmelpilze beim atopischen Ekzem. Allergologie 1995; 18: 425–428.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nenoff, P., Müller, B., Sander, U. et al. IgG and IgE immune response against the surface glycoprotein gp200 of Saccharomyces cerevisiae in patients with atopic dermatitis. Mycopathologia 152, 15–21 (2001). https://doi.org/10.1023/A:1011994120527
Issue Date:
DOI: https://doi.org/10.1023/A:1011994120527